jsc2025e007242

jsc2025e007242 (11/8/2024) --- A preflight image of BioServe’s BioCells a the start of the experiment for the expansion of the cells over 3 passages. Image courtesy of BioServe. In-Space Production of Induced Pluripotent Stem Cells for Clinical Application (StemCellEx-IP1) evaluates using microgravity to expand and mass-produce human induced pluripotent stem cells (iPSCs). Because they can transform into any type of cell in the body, iPSCs are being used to develop regenerative medicine therapies for many diseases. Producing iPSCs in space could lead to the ability to generate a greater number of high quality cells, significantly improving patient outcomes for many currently uncurable diseases here on Earth.